Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) Assets Average (2016 - 2026)

Perspective Therapeutics' Assets Average history spans 15 years, with the latest figure at $338.9 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 1.09% to $338.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $338.9 million, a 1.09% increase, with the full-year FY2025 number at $304.0 million, up 38.52% from a year prior.
  • Assets Average hit $338.9 million in Q1 2026 for Perspective Therapeutics, up from $280.9 million in the prior quarter.
  • Over the last five years, Assets Average for CATX hit a ceiling of $388.5 million in Q3 2024 and a floor of $60.3 million in Q4 2022.
  • Historically, Assets Average has averaged $208.5 million across 5 years, with a median of $188.1 million in 2024.
  • Biggest five-year swings in Assets Average: surged 251.35% in 2024 and later decreased 23.28% in 2025.
  • Tracing CATX's Assets Average over 5 years: stood at $60.3 million in 2022, then skyrocketed by 72.77% to $104.2 million in 2023, then surged by 251.35% to $366.1 million in 2024, then dropped by 23.28% to $280.9 million in 2025, then rose by 20.64% to $338.9 million in 2026.
  • Business Quant data shows Assets Average for CATX at $338.9 million in Q1 2026, $280.9 million in Q4 2025, and $302.8 million in Q3 2025.